Haojun Ma Selected Research

Dehydroascorbic Acid

1/2018	Dehydroascorbic Acid and pGPMA Dual Modified pH-Sensitive Polymeric Micelles for Target Treatment of Liver Cancer.
3/2015	Cell microenvironment-controlled antitumor drug releasing-nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy.
2/2014	Smart nanodevice combined tumor-specific vector with cellular microenvironment-triggered property for highly effective antiglioma therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haojun Ma Research Topics

Disease

12	Neoplasms (Cancer) 01/2018 - 10/2011
8	Glioma (Gliomas) 01/2016 - 10/2011
3	Brain Neoplasms (Brain Tumor) 10/2014 - 10/2011
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 03/2015
2	Parkinson Disease (Parkinson's Disease) 10/2013 - 01/2013
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Ischemic Stroke 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 02/2016
1	Brain Diseases (Brain Disorder) 02/2016
1	Cardiotoxicity 09/2015
1	Body Weight Changes 09/2015
1	Glioblastoma (Glioblastoma Multiforme) 09/2015
1	Breast Neoplasms (Breast Cancer) 03/2015
1	Meningitis 10/2014
1	Pneumonia (Pneumonitis) 10/2014
1	Reperfusion Injury 11/2013
1	Cerebral Infarction 11/2013
1	Brain Ischemia (Cerebral Ischemia) 11/2013
1	Inflammation (Inflammations) 01/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2012

Drug/Important Bio-Agent (IBA)

6	LigandsIBA 09/2015 - 10/2011
5	Pharmaceutical PreparationsIBA 02/2016 - 03/2013
4	MicellesIBA 01/2018 - 03/2015
4	Peptides (Polypeptides)IBA 02/2016 - 11/2013
3	Dehydroascorbic AcidIBA 01/2018 - 02/2014
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 03/2013
3	Choline (Choline Chloride)IBA 09/2015 - 01/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 03/2013
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 03/2015 - 02/2014
2	Glutathione (Reduced Glutathione)IBA 01/2015 - 02/2014
2	Small Interfering RNA (siRNA)IBA 01/2015 - 11/2013
2	AcidsIBA 11/2013 - 01/2013
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 07/2013 - 03/2013
2	DNA (Deoxyribonucleic Acid)IBA 07/2013 - 10/2011
2	Caspase 3 (Caspase-3)IBA 01/2013 - 10/2012
1	PolymersIBA 01/2018
1	methacrylamideIBA 01/2018
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2016
1	Fluorescent Dyes (Fluorescent Probes)IBA 03/2015
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 03/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2015
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2015
1	Antineoplastic Agents (Antineoplastics)IBA 03/2015
1	Cyclic PeptidesIBA 01/2015
1	Laminin (Merosin)IBA 10/2014
1	choline transporterIBA 12/2013
1	MAP Kinase Kinase Kinase 5IBA 11/2013
1	Proteins (Proteins, Gene)FDA Link 11/2013
1	dermorphinIBA 11/2013
1	Messenger RNA (mRNA)IBA 11/2013
1	Neuroprotective AgentsIBA 10/2013
1	RotenoneIBA 10/2013
1	Lysine (L-Lysine)FDA Link 10/2013
1	LuciferasesIBA 09/2013
1	Transferrin (beta 2 Transferrin)IBA 09/2013
1	tumstatin (74-98)IBA 09/2013
1	RNA (Ribonucleic Acid)IBA 03/2013
1	Contrast MediaIBA 01/2013
1	GadoliniumIBA 01/2013
1	Gadolinium DTPA (Magnevist)FDA Link 01/2013
1	rabies virus glycoprotein peptideIBA 01/2013
1	Therapeutic UsesIBA 01/2013
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2013
1	Angiopep-2IBA 10/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2011
1	Temozolomide (Temodar)FDA LinkGeneric 10/2011

Therapy/Procedure

10	Therapeutics 01/2021 - 03/2013
4	Drug Therapy (Chemotherapy) 01/2016 - 03/2013
1	Nanospheres 01/2015
1	Intravenous Injections 10/2014
1	RNAi Therapeutics 09/2013
1	Intravenous Administration 01/2013